Ylanan, Almari Faith C.

HRN: 28-62-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/02/2026
03/08/2026
IVT
105mg
Q8H
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines